Skip to main content
. 2014 Apr 28;25(1):79–98.

Table 1.

Differentially expressed miRNAs in prostate cancer.

Up-regulated miRNAs Down-regulated miRNAs Methods Number of clinical tissue samples/PCa vs. normal Refs
202, 210, 296, 320,
370, 498, 503, 373*		 Iet7a-d, Iet7g, 16, 23a,
b, 26a, 92, 99a, 103,
125a-b, 143, 145, 195,
199a, 221, 222, 497

  • MA

  • 5 primary PCa4 hormone - refractory PCa(±hormonaltreatment) 4 BPH

 (15)
7d, 195, 203, 34a, 20a,
29a, 25, 95, 197, 1352,
187, 1961, 148, 191, 21,
7i, 198, 199a-2, 30c, 17-5p,
92-2, 146, 181bl, 32,
206, 184prec, 29a prec,
29b-2, 181b, 196prec, 93,
223, 16, 101, 124a, 26a,
214, 27a, 106a, 199a		 128a, let7a-2, 218-2,
29a, 149, 24-1

  • MA

  • 56 primary PCa7 normal prostate tissues

 (18)
32, 182, 31, 26a, 200c, 375,
196a, 370, 425, 194, 181a,
34b, 7i, 188, 25, 106b, 449,
99b, 93, 92, 125		 520h, 494, 490, 133a,
l, 218, 220, 128a, 221,
499, 329, 340, 345,
410, 126, 205, 7, 145, 34a, 487, Iet7b

  • MART-qPCR

  • 60 primary PCa(no hormonaltherapy)16 Normal

 (19)
Let family, 34a, 29a, 16 145, let-7 (7b-g, 7i),
26a-b, 29a-c, 30a-e,
99a-b, 125a-b, 200a-b

  • MART-qPCR

  • 16 PCa30 PCa with relapse10 Normal tissue

 (20)
141, 20a 23b, 100, 145, 221, 222, 143

  • mirMA-SART-qPCR

  • 40 PCaNormal adjacent tissue

 (21)
524*, 182*, 183, 634, 96,
182, 130b, 375		 205, 222, 221, 368,
181b, 149, 3 1, 16184.145, 125b

  • MART-qPCR

  • 76 PCaNormal adjacent tissue

 (22)
Let7a, 17, 21, 93, 101,
141, 182, 375, 720,
1826, 12745, 106a,
106b, 200b, 200c, 20a,
20b, 768-3p		 136*, 145, 214, 221, 222, 302d*, 375*

  • MART-qPCR

  • 20 PCaNormal adjacent tissue

 (23)
Let7, 1, 98, 126, 132,
142, 143, 144, 205, 210		 34c, 29b, 212, 10b

  • RT-qPCR

  • 37 PCaNormal adjacent tissue

 (24)